We serve TERT-BUTYL N-(2-HYDROXYETHYL)CARBAMATE CAS:26690-80-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: TERT-BUTYL N-(2-HYDROXYETHYL)CARBAMATE
CAS.NO: 26690-80-2
Molecular Formula: C7H15NO3
Molecular Weight: 161.19900
Synonyms:
N-(t-butoxycarbonyl)-2-hydroxy-ethylamine
N-(tert-Butoxycarbonyl)ethanolamine
2-(Boc-amino)-1-ethanol
N-(2-Hydroxyethyl)carbamic Acid tert-Butyl Ester
boc-aminoethanol
Boc-Gly-ol
Boc-glycinol
tert-Butyl N-(2-Hydroxyethyl)carbamate
2-(tert-butoxycarbonylamino)ethanol
tert-butyl N-(2-hydroxyethyl)-carbamate
tert-Butyl (2-hydroxyethyl)carbamate
(2-hydroxyethyl)carbamic acid t-butyl ester
Boc-NH-(CH2)2-1-naphthylamide
boc-ethanolamine
Boc-2-aminoethanol
2-Boc-ethanolamine
2-(tert-Butoxycarbonyl)ethanolamine
2-(tert-ButoxycarbonylaMino)-1-ethanol
(2-hydroxy-ethyl)-carbamic acid tert-butyl ester
N-Boc-Ethanolamine
Physical and Chemical Properties:
Density: 1.042 g / mL at 25 ° C (lit.)
Boiling point: 267.2ºC at 760 mmHg
Flash point:> 230 ° F
Refractive index: n20 / D 1.449 (lit.)
Specification:
Appearance: Light yellow liquid
Purity:≥98%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Storage at 2-8ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:Pharmaceutical intermediates.
Contact us for information like TERT-BUTYL N-(2-HYDROXYETHYL)CARBAMATE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-Boc-Ethanolamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Boc-NH-(CH2)2-1-naphthylamide Use and application,N-Boc-Ethanolamine technical grade,usp/ep/jp grade.
Related News: INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.2-Chloroanisole manufacturer INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.4-Bromo-3-fluoroanisole supplier Subsequently, the company launched the drug under the brand names ‘Remo’ and ‘Remozen’.1,2,3-Trifluorobenzene vendor At present, Linhai, Zhejiang Province, has established a national chemical raw material base in Zhejiang Province, which is the earliest and largest gathering area of ??domestic chemical raw material medicines and pharmaceutical intermediate industries.“CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,” said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.
